Patent ID: 6903091

Claim:
A method of treating disorders which are remedied or alleviated by vasopressin agonist activity in a mammal in need thereof, the method comprising administering to the mammal a pharmaceutically effective amount of a compound of Formula (I): wherein: Y is a moiety selected from CH 2 ; represents a phenyl ring optionally substituted with one or two substituents selected, independently, from the group comprising hydrogen, (C 1 -C 6 ) lower alkyl, halogen, cyano, CF 3 , hydroxy, (C 1 -C 6 ) lower alkoxy, (C 1 -C 6 ) lower alkoxy carbonyl, carboxy, —CONH 2 , —CONH[(C 1 -C 6 ) lower alkyl], —CON[(C 1 -C 6 ) lower alkyl] 2 ; represents a 5-membered aromatic (unsaturated) heterocyclic ring having one nitrogen atom, optionally substituted by (C 1 -C 6 ) lower alkyl, (C 1 -C 6 ) lower alkoxy, or halogen; R 1 is a moiety of the formula and R 2 , R 7 , R 8 and R 9 are, independently, selected from the group consisting of hydrogen, (C 1-C 3 ) lower alkyl, OCH 3 , halogen, CF 3 , —SCH 3 , OCF 3 , SCF 3 , or CN; or a pharmaceutically acceptable salt, or pro-drug form thereof.